Cell therapy wins FDA recommendation

Posted: 07/14/2017

The US FDA’s recommended approval of Novartis’ CAR-T cell therapy pushes the product closer to being the first treatment of its kind available on the market.Bruno Strigini, CEO, Novartis Oncology said: "The panel's unanimous recommendation in favor of CTL019 moves us closer to potentially delivering the first-ever commercially approved CAR-T

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Posted: 07/14/2017

Pharma IQ Members


The Westin Grand Munich, Munich, Germany
April 16 - 18, 2018
InterContinental Shanghai Pudong Hotel, Shanghai, China
April 22 - 23, 2018